Global Autologous Transfusion Products Market Growth 2025-2031
Description
The global Autologous Transfusion Products market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
Autologous Transfusion Products are products that collect, process and preserve a patient"s own blood for use in situations where a patient requires transfusion during surgery or other medical procedures. Compared with traditional donor blood, autologous blood transfusion products can avoid potential risks such as infection and immune reaction transmitted by donor blood, and can also reduce problems such as shortage of donor blood and cost of donor blood.
United States market for Autologous Transfusion Products is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Autologous Transfusion Products is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Autologous Transfusion Products is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Autologous Transfusion Products players cover LivaNova, Haemonetics, Getinge AB, Medtronic, Terumo, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “Autologous Transfusion Products Industry Forecast” looks at past sales and reviews total world Autologous Transfusion Products sales in 2024, providing a comprehensive analysis by region and market sector of projected Autologous Transfusion Products sales for 2025 through 2031. With Autologous Transfusion Products sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Autologous Transfusion Products industry.
This Insight Report provides a comprehensive analysis of the global Autologous Transfusion Products landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Autologous Transfusion Products portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Autologous Transfusion Products market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Autologous Transfusion Products and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Autologous Transfusion Products.
This report presents a comprehensive overview, market shares, and growth opportunities of Autologous Transfusion Products market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Intraoperative Autologous Transfusion Products
Postoperative Autologous Transfusion Products
Dual Mode Autologous Transfusion Products
Segmentation by Application:
Organ Transplant Surgery
Orthopedic Surgery
Heart Surgery
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
LivaNova
Haemonetics
Getinge AB
Medtronic
Terumo
Braile Biomedica
Fresenius Kabi
Appligent
Wandong Health Sources
Advancis Surgical
Macopharma SA
Asahi Kasei Medical
Stryker Corporation
Zimmer Biomet Holdings
Key Questions Addressed in this Report
What is the 10-year outlook for the global Autologous Transfusion Products market?
What factors are driving Autologous Transfusion Products market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Autologous Transfusion Products market opportunities vary by end market size?
How does Autologous Transfusion Products break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
Autologous Transfusion Products are products that collect, process and preserve a patient"s own blood for use in situations where a patient requires transfusion during surgery or other medical procedures. Compared with traditional donor blood, autologous blood transfusion products can avoid potential risks such as infection and immune reaction transmitted by donor blood, and can also reduce problems such as shortage of donor blood and cost of donor blood.
United States market for Autologous Transfusion Products is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Autologous Transfusion Products is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Autologous Transfusion Products is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Autologous Transfusion Products players cover LivaNova, Haemonetics, Getinge AB, Medtronic, Terumo, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “Autologous Transfusion Products Industry Forecast” looks at past sales and reviews total world Autologous Transfusion Products sales in 2024, providing a comprehensive analysis by region and market sector of projected Autologous Transfusion Products sales for 2025 through 2031. With Autologous Transfusion Products sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Autologous Transfusion Products industry.
This Insight Report provides a comprehensive analysis of the global Autologous Transfusion Products landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Autologous Transfusion Products portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Autologous Transfusion Products market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Autologous Transfusion Products and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Autologous Transfusion Products.
This report presents a comprehensive overview, market shares, and growth opportunities of Autologous Transfusion Products market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Intraoperative Autologous Transfusion Products
Postoperative Autologous Transfusion Products
Dual Mode Autologous Transfusion Products
Segmentation by Application:
Organ Transplant Surgery
Orthopedic Surgery
Heart Surgery
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
LivaNova
Haemonetics
Getinge AB
Medtronic
Terumo
Braile Biomedica
Fresenius Kabi
Appligent
Wandong Health Sources
Advancis Surgical
Macopharma SA
Asahi Kasei Medical
Stryker Corporation
Zimmer Biomet Holdings
Key Questions Addressed in this Report
What is the 10-year outlook for the global Autologous Transfusion Products market?
What factors are driving Autologous Transfusion Products market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Autologous Transfusion Products market opportunities vary by end market size?
How does Autologous Transfusion Products break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
110 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 Global by Company
- 4 World Historic Review for Autologous Transfusion Products by Geographic Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Manufacturing Cost Structure Analysis
- 11 Marketing, Distributors and Customer
- 12 World Forecast Review for Autologous Transfusion Products by Geographic Region
- 13 Key Players Analysis
- 14 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
